NLRP3 and atrial fibrillation: Since BMP2 suppresses fibroblast activation and restrains NLRP3-driven inflammation, its inhibition promoted a profibrotic, proinflammatory phenotype, exacerbating molecular processes that drive atrial fibrosis and AF pathogenesis [10].